Over the last 7 days, the Biotech industry has remained flat, although notably Telix Pharmaceuticals declined by 4.8%. The past year has been better, since the industry has gained 4.9% in that time. As for the next few years, earnings are expected to grow by 16% per annum.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 15 Jun 2024 | AU$150.5b | AU$22.3b | AU$3.3b | 31x | 46x | 6.8x |
Mon, 13 May 2024 | AU$144.8b | AU$22.2b | AU$3.3b | 30.7x | 44.5x | 6.5x |
Wed, 10 Apr 2024 | AU$144.1b | AU$22.2b | AU$3.2b | 30.8x | 44.4x | 6.5x |
Fri, 08 Mar 2024 | AU$143.6b | AU$22.2b | AU$3.3b | 29.3x | 44.1x | 6.5x |
Sun, 04 Feb 2024 | AU$152.4b | AU$21.0b | AU$2.8b | 34.6x | 54.5x | 7.2x |
Tue, 02 Jan 2024 | AU$145.8b | AU$20.2b | AU$2.7b | 34.6x | 54.9x | 7.2x |
Thu, 30 Nov 2023 | AU$133.7b | AU$20.7b | AU$2.7b | 33.9x | 48.7x | 6.5x |
Sat, 28 Oct 2023 | AU$119.1b | AU$21.6b | AU$2.9b | 28.7x | 41.2x | 5.5x |
Mon, 25 Sep 2023 | AU$129.2b | AU$21.3b | AU$2.8b | 30.4x | 46.2x | 6.1x |
Wed, 23 Aug 2023 | AU$136.4b | AU$21.1b | AU$2.5b | 38.4x | 53.7x | 6.5x |
Fri, 21 Jul 2023 | AU$137.2b | AU$17.6b | AU$2.3b | 37.9x | 60.7x | 7.8x |
Sun, 18 Jun 2023 | AU$143.0b | AU$17.5b | AU$2.2b | 39.1x | 63.7x | 8.2x |
Tue, 16 May 2023 | AU$157.5b | AU$18.0b | AU$2.3b | 41.9x | 67.9x | 8.8x |
Thu, 13 Apr 2023 | AU$154.6b | AU$18.0b | AU$2.3b | 42x | 66.5x | 8.6x |
Sat, 11 Mar 2023 | AU$146.1b | AU$18.2b | AU$2.4b | 39.3x | 61.8x | 8x |
Mon, 06 Feb 2023 | AU$159.7b | AU$15.6b | AU$2.5b | 52.2x | 64.8x | 10.3x |
Wed, 04 Jan 2023 | AU$146.9b | AU$15.8b | AU$2.5b | 45.9x | 58.3x | 9.3x |
Fri, 02 Dec 2022 | AU$152.9b | AU$16.0b | AU$2.6b | 44.7x | 59.7x | 9.5x |
Sun, 30 Oct 2022 | AU$140.3b | AU$16.8b | AU$2.7b | 40.9x | 52.1x | 8.4x |
Tue, 27 Sep 2022 | AU$144.6b | AU$16.4b | AU$2.6b | 40.4x | 54.9x | 8.8x |
Thu, 25 Aug 2022 | AU$146.7b | AU$15.5b | AU$2.7b | 39.8x | 55.2x | 9.5x |
Sat, 23 Jul 2022 | AU$149.9b | AU$15.6b | AU$2.8b | 38.1x | 53.1x | 9.6x |
Mon, 20 Jun 2022 | AU$128.9b | AU$15.6b | AU$2.8b | 33.1x | 45.7x | 8.3x |
Wed, 18 May 2022 | AU$138.5b | AU$15.6b | AU$2.8b | 36.3x | 49.3x | 8.9x |
Fri, 15 Apr 2022 | AU$134.9b | AU$14.5b | AU$2.6b | 38.3x | 51.3x | 9.3x |
Sun, 13 Mar 2022 | AU$131.1b | AU$14.7b | AU$2.7b | 39x | 49.1x | 8.9x |
Tue, 08 Feb 2022 | AU$131.8b | AU$14.8b | AU$2.8b | 36.3x | 46.6x | 8.9x |
Thu, 06 Jan 2022 | AU$151.0b | AU$14.5b | AU$2.8b | 42.4x | 54.8x | 10.4x |
Sat, 04 Dec 2021 | AU$147.6b | AU$14.7b | AU$2.8b | 40.6x | 52.5x | 10x |
Mon, 01 Nov 2021 | AU$149.5b | AU$14.0b | AU$2.6b | 43.3x | 56.9x | 10.7x |
Wed, 29 Sep 2021 | AU$147.0b | AU$14.4b | AU$2.7b | 41.2x | 54.2x | 10.2x |
Fri, 27 Aug 2021 | AU$153.4b | AU$14.0b | AU$2.6b | 44.7x | 58.4x | 11x |
Sat, 03 Jul 2021 | AU$141.3b | AU$14.0b | AU$2.6b | 41x | 53.8x | 10.1x |
53.8x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | -1.68% | |
Healthcare | -0.085% | |
Biotech | -0.17% | |
Biotech | -0.17% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
OPT Opthea | AU$0.36 | -24.7% AU$76.9m | -34.8% | PS675x | |
IMM Immutep | AU$0.41 | -4.7% AU$72.9m | 36.7% | PS148.6x | |
CSL CSL | AU$289.10 | 0.03% +AU$48.3m | 4.0% | PE37.4x | |
MSB Mesoblast | AU$1.08 | 3.3% +AU$39.9m | -1.8% | PS109.2x | |
DXB Dimerix | AU$0.65 | 12.2% +AU$38.5m | 1,012.1% | PS38.9x |